April 12, 2017
Claim deadline to receive settlement funds extended to June 25
Carson City, NV – Nevada Attorney General Adam Paul Laxalt urges eligible Nevadans who feel they may be entitled to relief to file claims or express views on the Provigil settlement before the new June 25, 2017 deadline. In August 2016, Nevada and 47 other state attorneys general announced a settlement with the biopharmaceutical company Cephalon and its affiliated companies. The settlement resolved allegations that Cephalon engaged in anticompetitive conduct to protect the monopoly profits for their Provigil drug. The $125 million multistate settlement provides $35 million to compensate eligible consumers who may have been harmed by the alleged conduct. The states’ sought and were granted the ability to extend the claim deadline from April 13 to June 25, 2017.
“Nevada’s eligible consumers are encouraged to file claims before the extended deadline,” said Laxalt. “My office will continue to put the needs and dollars of Nevadans first, and will work with other states and agencies to provide relief to all those affected by this alleged anticompetitive conduct.”
Provigil, which includes the active ingredient modafinil, is approved by the federal Food and Drug Administration (FDA) to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder.
Nevada consumers who paid for Provigil or generic modafinil between June 24, 2006 and March 31, 2012 are eligible to participate. Those who wish to file a claim may do so by visiting http://www.stateagprovigilsettlement.com or calling 1-877-236-1413. Nevadans have until June 25, 2017 to file a claim.
The order granting the extension of the claims deadline is attached.